Follow the Ypsomed Holding AG stock price and the full management transaction log of the company, a listed equity based in Switzerland. Shares are quoted on the CH market, under the supervision of SIX SER. Operating in the Health Care sector, Ypsomed Holding AG has published 16 public disclosures. Market capitalisation: €5.2bn. The latest transaction was reported on 24 July 2026 (Sale). All data is openly available.
16
Insider Decl.
n/a
Thresholds
€325,881
7 ops.
Buy Volume
€1m
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ypsomed Holding AG Buy (bullish), based on 13 analysts. Average price target: CHF 391.15.
26Σ signal
Buys €325,881€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,037 of 28,822 companies
60.8
score / 100
Value
42
Quality
80
FCF yld-0.3%
Earn yld4.1%
EV/EBITDA17.3x
ROE31%
Gross mgn43%
Net mgn30%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2026
Declarations16 total
●
Anonymous (a non-executive member of the board of directors)
a non-executive member of the board of directors·Executives·(filed)
150 shares@ CHF 272.000.0009% mcap100.0% of flowISINISIN CH0019396990SIX:T1N9T00027
16 of 16 declarations
About Ypsomed Holding AG
Ypsomed Holding AG is a Swiss company that specializes in the development and manufacturing of drug delivery systems, particularly injection devices. It focuses on solutions for diabetes and other chronic diseases.